Collaborating with ARMoR and the World Bank on antimicrobial resistance policy papers sparked a personal interest in exploring how improving access to existing antibiotics could reduce the burden of drug-resistant infections. This piece is a work in progress — an independent research and writing project developed to deepen my understanding and communicate the potential impact clearly and credibly.
